Regulatory & Medical Affairs
Provides medical support to marketed products via publications and scientific symposia. Brings medical expertise to marketing strategy as well as expertise for the skin diseases explored and treatments developed by Galderma. Manages communications with the medical community through congresses, Internet and other channels.
Ensures that the benefit-risk balance of developed and marketed drugs is well understood and managed to ensure the patient's and company's protection. Monitors, assesses and reports to the authorities adverse events related to Galderma's dermatological products.
Establishes the regulatory strategy for new dermatological solutions, compiles and publishes submission dossiers (paper or electronic) for each target country or region and supports the registration process. Coordinates the modification and renewal of existing Marketing Authorizations as required by internal or external developments and regulations.